期刊文献+

ABO血型主要不合供者外周血干细胞单采中COM.TEC血细胞分离机的应用 被引量:2

Harvesting peripheral blood stem cells from major ABO mismatched donors using COM.TEC blood cell separator
在线阅读 下载PDF
导出
摘要 背景:异基因外周血造血干细胞移植大约1/3是在ABO血型不合的供受者之间进行的。目的:探讨ABO血型主要不合供者外周血造血干细胞在不去除红细胞情况下应用COM.TEC血细胞分离机直接回输给受者的可行性。方法:27例HLA全相合同胞供者皮下注射粒细胞集落刺激因子5μg/(kg?d),连续5d干细胞动员,于第5天开始应用COM.TEC血细胞分离机进行外周血造血干细胞单采,每次总处理血量为3.0~3.5个供者全身血量。ABO相合供者按常规方法进行单采,主要不合供者采取动态调整白膜收集量和保持稳定充足的血流量以减少红细胞污染。结果与结论:27例供者中ABO主要不合供者11例,相合供者16例。主要不合组产品体积及红细胞内含量均显著低于相合组(P<0.05),回输给受者均未出现急性溶血反应;2组单个核细胞及CD34+细胞计数差异无显著性意义(P>0.05),受者均获造血重建,中性粒细胞及血小板重建时间相似(P>0.05)。提示应用COM.TEC血细胞分离机进行ABO主要不合供者外周血造血干细胞单采,可以保持稳定充足的血流量情况下通过动态调整白膜收集量参数,在不影响采集产品产量和质量的同时显著减少红细胞的污染,预防回输后受者的急性溶血反应。 BACKGROUND:Approximately 1/3 allogeneic peripheral blood stem cells(PBSCs) transplantation treatments are performed between ABO mismatched donors-recipients pairs.OBJECTIVE:To evaluate the feasibility of PBSCs collection in major ABO mismatched donors with COM.TEC blood cell separator and infusion to the recipients without removal of erythrocytes from the PBSCs graft.METHODS:Twenty-seven HLA-identical sibling donors received priming with granulocyte colony stimulating factor(G-CSF) 5 μg/kg/d via subcutaneous injection for 5 days.PBSCs collection started on day 5 using COM.TEC blood cell separator.The procedure processed 3.0-3.5 times of the total blood volume(TBV).For major ABO mismatched donors,specialized harvesting strategies of adjusting the volume of buffy coat and maintaining adequate and stable flow rate during apheresis were to diminish red blood cells(RBCs) contents of PBSCs.RESULTS AND CONCLUSION:Of the 27 donors,there were 11 major ABO-incompatible and 16 ABO-identical.The volumes of PBSCs graft and RBCs harvested in major ABO-incompatible group were significantly lower than those of ABO-identical group(P〈0.05).The number of mononuclear cells and CD34+ cells per recipient body weight did not statistically differ between the two groups(P〈0.05).All recipients reconstituted hematopoiesis following allo-PBSCT.Mean time to neutrophil and platelet engraftment was no significant difference between ABO-identical and major incompatible transplantaions(P〈0.05).PBSC harvesting from major ABO mismatched donors can be successfully performed with COM.TEC blood cell separator.Adjustment the volume of buffy coat and maintenance of adequate and stable flow rate during procedure can reduce RBC contamination for prevention of immune hemolysis;meanwhile collecting a sufficient number of CD34+ cells to ensure prompt engraftment post-transplantation.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第36期6781-6784,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
作者简介 王荷花,女,1972年生,江西省南昌市人,汉族,2004年中国协和医科大学毕业,博士,主治医师,主要从事造血干细胞移植的研究。md.vicky@gmail.com
  • 相关文献

参考文献20

  • 1Gratwohl A,Baldomero H,Horisberger B,et al.Current trends in hematopoietic stem cell transplantation in Europe.Blood.2002; 100(7):2374-2386.
  • 2Stem Cell Trialists' Collaborative Group.Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies:an individual patient data meta-analysis of nine randomized trials.J Clin Oncol.2005; 23(22):5074-5087.
  • 3Gratwohl A,Baldomero H,Schmid O,et al.Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe:a report of the EBMT activity survey 2003.Bone Marrow Transplant.2005;36(7):575-590.
  • 4Gratwohl A,Baldomero H,Schwendener A,et al.The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.Bone Marrow Transplant.2009;43(4):275-291.
  • 5Rowley SD,Liang PS,Ulz L.Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.Bone Marrow Transplant.2000;26(7):749-757.
  • 6Rowley SD.Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs.Bone Marrow Transplant.2001;28(4):315-321.
  • 7Stussi G,Muntwyler J,Passweg JR,et al.Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant.2002;30(2):87-93.
  • 8Seebach JD,Stussi G,Passweg JR,et al.ABO blood group barrier in allogeneic bone marrow transplantation revisited.Biol Blood Marrow Transplant.2005;11(12):1006-1013.
  • 9Kishimoto M,Ohto H,Shikama Y,et al.Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.Transfusion.2002;42(10):1340-1347.
  • 10陈惠珍,许多荣,邹外一,陈运贤,李娟.三种补钙方法在预防外周血造血干细胞采集中枸橼酸盐中毒的效果比较[J].中国实用医刊,2010,37(7):5-7. 被引量:6

二级参考文献25

  • 1Balint B, Ljubenov M, Stamatovic D, et al. Stem cell harvesting protocol research in autologous transplantation setting: large volume vs. conventional cytapheresis. Vojnosanit Pregl 2008;65(7):545-551.
  • 2Pusic I, DiPersio JF. The use of growth factors in hematopoietic stem cell transplantation. Curt Pharm Des. 2008; 14(20): 1950-1961.
  • 3Moog R. Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther 2006; 1 (2): 189-201.
  • 4Moog R. Apheresis techniques for collection of peripheral blood progenitor cells. Transfus Apher Sci 2004;31 (3):207-220.
  • 5Burger SR, Fautsch SK, Stroncek DE et al. Concentration of citrate anticoagulant in peripheral blood progenitor cell collections. Transfusion 1996; 36(9): 798-801.
  • 6Kishimoto M, Ohto H, Shikama Y, et al. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting. Transfusion 2002; 42(10): 1340-1347.
  • 7Heuft HG, Dubiel M, Kingreen D, et al. Automated collection of peripheral blood stern cells with the COBE spectra for autotransplantation.Vox Sang 2000;79(2):94-99.
  • 8Buchta C, Macher M, Bieglmayer C, et al. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate. Transfusion 2003;43 ( 11 ): 1615-1621.
  • 9Gasova, Z, Marinov I, Vodvarkova S, et al. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients. Transfus Apher Sci 2005; 32(2):167-176.
  • 10Hitzler WE, Wolf S, Runkel S, et al. Comparison of intermittent-and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies. Transfusion 2001; 41(12):1562-1566.

共引文献25

同被引文献3

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部